# Patrick Hwu

Source: https://onco.cc/people/patrick-hwu/  
OnCo record `patrick-hwu` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Patrick Hwu is an immunotherapy pioneer who trained with Rosenberg and now leads Moffitt.

## Summary

Patrick Hwu is President and Chief Executive Officer of Moffitt Cancer Center. He is a tumour immunologist and immunotherapy pioneer who trained with Steven Rosenberg and helped develop tumour-infiltrating lymphocyte and gene-modified T cell therapies at the National Cancer Institute and MD Anderson. His selected paper reviews adoptive cell therapy for melanoma. He became Moffitt's chief executive in 2020 and retains interests in TIL and TCR-T cell therapy for melanoma.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: President and Chief Executive Officer
- Specialisms: Tumour immunology; Adoptive cell therapy; Melanoma

## Sources

- Moffitt leadership: https://www.moffitt.org/about-moffitt/leadership/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Hwu%20P%5BAuthor%5D

## Connected records

- cancers: [Melanoma](https://onco.cc/cancers/melanoma/)
- technologies: [TCR-T cell therapy](https://onco.cc/technologies/tcr-t/), [TIL therapy](https://onco.cc/technologies/til-therapy/)
- institutions: [Moffitt Cancer Center](https://onco.cc/institutions/moffitt/), [Society for Immunotherapy of Cancer](https://onco.cc/institutions/sitc/)
- journals: [The cancer journal](https://onco.cc/journals/the-cancer-journal/)

---
JSON: https://onco.cc/api/v1/entities/patrick-hwu.json